Procaps Group SA (PROC) - Total Assets
Based on the latest financial reports, Procaps Group SA (PROC) holds total assets worth $498.55 Million USD as of September 2023. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Procaps Group SA to assess how comfortably operating cash covers total debt obligations.
Procaps Group SA - Total Assets Trend (2019–2022)
This chart illustrates how Procaps Group SA's total assets have evolved over time, based on quarterly financial data. See PROC net asset value for net asset value and shareholders' equity analysis.
Procaps Group SA - Asset Composition Analysis
Current Asset Composition (December 2022)
Procaps Group SA's total assets of $498.55 Million consist of 64.6% current assets and 35.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.3% |
| Accounts Receivable | $153.26 Million | 33.3% |
| Inventory | $96.83 Million | 21.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $32.21 Million | 7.0% |
| Goodwill | $5.79 Million | 1.3% |
Asset Composition Trend (2019–2022)
This chart illustrates how Procaps Group SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Procaps Group SA stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Procaps Group SA's current assets represent 64.6% of total assets in 2022, an increase from 51.1% in 2019.
- Cash Position: Cash and equivalents constituted 9.3% of total assets in 2022, up from 0.6% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, unchanged from 8.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 33.3% of total assets.
Procaps Group SA Competitors by Total Assets
Key competitors of Procaps Group SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.84 Billion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.69 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
|
China | CN¥6.39 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.23 Billion |
Procaps Group SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.47 | 1.38 | 0.69 |
| Quick Ratio | 0.99 | 0.93 | 0.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $95.42 Million | $83.91 Million | $-19.01 Million |
Procaps Group SA - Advanced Valuation Insights
This section examines the relationship between Procaps Group SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 64.34 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | -0.4% |
| Total Assets | $460.19 Million |
| Market Capitalization | $113.95 Million USD |
Valuation Analysis
Below Book Valuation: The market values Procaps Group SA's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Procaps Group SA's assets decreased by 0.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Procaps Group SA (2019–2022)
The table below shows the annual total assets of Procaps Group SA from 2019 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $460.19 Million | -0.42% |
| 2021-12-31 | $462.13 Million | +28.54% |
| 2020-12-31 | $359.54 Million | +6.46% |
| 2019-12-31 | $337.73 Million | -- |
About Procaps Group SA
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use… Read more